Loading
Latest filing published 12 Aug 2026 for NextCure, Inc., €160k.
No signal scores available.
One trade, one date: on 12 August 2026, Simcere Zaiming, Inc. disclosed an open-market sale of €160k in NextCure, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration